FDA scientists opposed the Trump administration's move to ease peptides access
Food and Drug Administration staffers had little input on the decision by the Trump administration that eases access to unproven peptide drugs favored by Health Secretary Robert…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 28 14:00 ETSource: Ottumwa Courier
From the source
Read at ottumwacourier.comFDA scientists opposed the Trump administration's move to ease peptides access
Food and Drug Administration staffers had little input on the decision by the Trump administration that eases access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr.. That’s according to people familiar with the policy’s development who were interviewed by The Associated Press. The new policy was posted online Wednesday by Kennedy’s Department of Health and Human Service
